scholarly journals Beers Criteria versus Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions in evaluation of drug-prescribing practice in an Indian hospital

2021 ◽  
Vol 47 (1) ◽  
Author(s):  
Gabriel Brito Procópio ◽  
Lino Afonso Canelas de Andrade ◽  
Ana Cristina Viana Campos

Objetivo: analisar o perfil farmacoterapêutico e o uso de medicamentos potencialmente inadequados entre idosos da área de abrangência da Primeira Igreja Batista em Novo Horizonte, Marabá – PA. Métodos: Estudo quantitativo exploratório realizado com 70 idosos. A classificação dos medicamentos em grupos foi realizada utilizando-se a Anatomical Therapeutic Chemical System Classification. Para seleção de medicamentos potencialmente inadequadas em idosos utilizamos o Screening Tool of Older Persons' potentially inappropriate Prescriptions. Resultados: A maioria dos idosos era do sexo feminino (59,7%), com média de idade em 73,8 anos (±9,0), escolaridade de ensino fundamental (56,5%). Dos 228 medicamentos distribuídos entre os 62 idosos, o uso médio foi de 3,7 (±2,1) medicamentos por idoso. Os medicamentos mais utilizados foram os anti-hipertensivos, tais como: Losartana Potássica (8,33%), Atenalol (3,95%) e Besilato de Anlodipino (3,51%). Os fármacos potencialmente inadequados para indicação em idosos, são: Glibenclamida, Ácido Acetilsalicílico, analgésico, antitérmico e a Nimisulida. Conclusão: A utilização de ferramentas em ações para a detecção de medicamentos potencialmente inapropriados, procedimentos e rotinas explícitas para a revisão de medicamentos devem ser adotados para investigação precípua em populações idosas.


2019 ◽  
Vol 10 ◽  
pp. 204062231987960 ◽  
Author(s):  
Chirn-Bin Chang ◽  
Hsiu-Yun Lai ◽  
Shinn-Jang Hwang ◽  
Shu-Yu Yang ◽  
Ru-Shu Wu ◽  
...  

Background: Explicit criteria for potentially inappropriate medications (PIMs) developed for other countries are difficult to apply to a specific territory. This study aimed to update the PIM-Taiwan criteria from a qualitative review of several published PIM criteria, followed by consensus among regional experts in Taiwan. Methods: After a review of the literature, we selected four sets of published PIM criteria to construct preliminary core PIMs. The Beers criteria, Fit fOR The Aged (FORTA), and Japan criteria were used for PIMs, without consideration of chronic diseases. The Beers criteria, Screening Tool of Older Persons’ Prescriptions (STOPP) criteria, and Japan criteria were used for PIMs with respect to chronic diseases. We asked experts ( n = 24) to rate their agreement with each statement, including in the final PIM criteria, after two rounds of modified Delphi methods. The intraclass coefficient (ICC) was used to examine the reliability of the modified Delphi method. Results: Overall, two categories of PIMs were established: 131 individual drugs and 9 drugs with combinations that should generally be avoided; and 9 chronic diseases with their corresponding PIMs that have drug–disease interactions. The ICC estimates for PIMs to be avoided generally were 0.634 and 0.557 (round 1 and 2) and those for PIMs with respect to chronic diseases were 0.866 and 0.775 (round 1 and 2) of the Delphi method, respectively. Conclusions: The 2018 version of PIM-Taiwan criteria was established and several modifications were made to keep the criteria updated and relevant. Clinicians can use them to reduce polypharmacy and PIMs among older patients.


Sign in / Sign up

Export Citation Format

Share Document